Tissue homeostasis is driven by a myriad of extracellular, intracellular and intercellular signaling networks. Direct communication between neighboring cells is typically controlled by gap junctions (Decrock et al. 2009; Nielsen et al. 2012; Vinken et al. 2011) . Gap junctions mediate the intercellular diffusion of small and hydrophilic substances, including cyclic adenosine monophosphate, adenosine triphosphate, inositol triphosphate, glutathione, glutamate, glucose and several ions (Alexander and Goldberg 2003) (Fig. 1a) . This flux is denoted as gap junctional intercellular communication (GJIC) and is considered as a key mechanism in the maintenance of tissue functioning (Decrock et al. 2009; Nielsen et al. 2012; Vinken et al. 2011) . Over the last decades, GJIC has been shown indispensable for the establishment of metabolic or electrical intercellular coupling in all vital organs, such as the brain (Eugenin et al. 2012) , the heart (Kurtenbach et al. 2014 ) and the liver (Vinken et al. 2008) . Gap junctions are formed by the docking of two hemichannels of adjacent cells, which in turn are composed of six connexin proteins. At present, 21 different connexins have been identified in humans, all which are expressed in a cell-specific way (Kar et al. 2012; Nielsen et al. 2012) . They are named based upon their molecular weight. Thus, the most widespread connexin species has a molecular mass of 43 kDa and hence is called Cx43. Connexin proteins share a common molecular structure consisting of four transmembrane domains, two extracellular loops, one cytosolic loop, one cytosolic aminotail and M. Vinken (*) Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium e-mail: mvinken@vub.ac.be triphosphate and signaling through connexin hemichannels (Bhabra et al. 2009 ).
The connexin research field has been surrounded by a lot of controversy in the last few years. Specifically, the concept of (dys) functional connexin hemichannels has been debated heavily on several occasions (Sáez and Leybaert 2014; Spray et al. 2006) . A major reason for this impediment is the ubiquitous lack of tools and technologies to distinguish between the different channel types, in casu between gap junctions and connexin hemichannels (Bodendiek and Raman 2010; Iyyathurai et al. 2013 ). Classical strategies, such as the use of RNA interference-based technologies, genetically modified animals or even antibodies, are indeed not applicable, as they target connexins, which are the shared building stones of gap junctions and connexin hemichannels. Furthermore, most, if not all, of the routinely used gap junction inhibitors, including longchain alcohol substances, anaesthetic substances, the glycyrrhetinic acid derivative carbenoxolone and the fenamate family of blockers, equally suppress connexin hemichannel activity (Bodendiek and Raman 2010) . Great expectations now lie with peptides that reproduce sequences in the cytosolic loop regions of connexins, as they suppress connexin hemichannel activity without influencing GJIC (Iyyathurai et al. 2013) . Among those, a very prominent one is Gap19, a peptide that inhibits Cx43-based hemichannels while leaving the corresponding gap junctions unaffected (Abudara et al. 2014; Wang et al. 2013 ). In fact, Gap19 was found to reduce experimentally induced cell death in a mouse model of cardiac ischemia-reperfusion ). This area is still in its infancy, but upon further exploration, it can be expected that this will also open new perspectives for the field of toxicology. Indeed, such specific connexin hemichannel inhibitors are not only interesting experimental tools to shed light onto yet unraveled toxicological mechanisms of action, but they may also form the basis for the development of antidotes pertinent for clinical use. 
